Skip to main content
. 2023 Jul 14;23:659. doi: 10.1186/s12885-023-11156-y

Table 3.

EGFR mutation and ALK in NSCLC according to the patients’ gender

No. of patients (%) (Total = 191) P value
Characteristics Total Male Female
EGFR mutation-positive 81 (42.4%) 31 (27.0%) 50 (65.8%)  < 0.0001
ALK-positive 8 (4.2%) 3 (2.6%) 5 (6.6%) 0.269